Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

Comment by 1hot-techwomanon Apr 03, 2022 10:49am
436 Views
Post# 34571068

RE:RE:RE:Significant rev's now for EU-GMP German Business !!

RE:RE:RE:Significant rev's now for EU-GMP German Business !!
Macpoor wrote: CTM,

We didn't see any news in past three months . I am thinking the 1Q will not be a good one. There was no shippment to Germany and Aussie during first Q


 -- In December 2021, recorded first significant revenues of Canadian produced EU-GMP product by VIVO's German business -- In mid 2021 the Company refined its strategy and is now focused primarily on medical cannabis -- The Company continues to have market leadership in Australia and leveraged its Canadian knowledge base to accelerate product efficacy, cannabis medical information sharing, and sales growth -- With the Company's EU-GMP certification, it is now in a position to repeat its Australian success in Germany and in other global markets, all of which are exclusively medically focused -- Over 350% year-over-year sales growth in Australia 
<< Previous
Bullboard Posts
Next >>